KYMR - Financial Reports List - Kymera Therapeutics, Inc. - IntrinsicAlpha

Kymera Therapeutics, Inc. KYMR

Healthcare - Biotechnology - NASDAQ - US

$ 28.5

4.58 %

$ 1.85 B

Market Cap

-9.11

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-84.56%	-392.43%	-318.16%
Annual Report	FY	10-K	2024-12-31	-40.11%	-52.32%	-58.06%
Quarterly Report	Q3	8-K	2024-09-30	-20.88%	-18.20%	-25.41%
Quarterly Report	Q2	8-K	2024-06-30	55.33%	-8.41%	-17.38%
Quarterly Report	Q1	8-K	2024-03-31	8.67%	-32.72%	-16.72%
Quarterly Report	Q4	8-K	2023-12-31	196.70%	57.80%	50.01%
Annual Report	FY	10-K	2023-12-31	67.84%	3.21%	-2.65%
Quarterly Report	Q3	8-K	2023-09-30	-50.50%	-22.94%	-28.13%
Quarterly Report	Q2	8-K	2023-06-30	43.42%	2.28%	-6.30%
Quarterly Report	Q1	8-K	2023-03-31	-1.62%	-0.41%	-22.72%

1